查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2044443

門診護理服務市場預測至2034年－按服務類型、機構類型、專科、所有權、交付方式、最終用戶和地區分類的全球分析

Ambulatory Services Market Forecasts to 2034 - Global Analysis By Service Type, Facility Type, Clinical Specialty, Ownership, Delivery Mode, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的預測，全球門診服務市場預計到 2026 年將達到 4,7,816 億美元，並在預測期內以 6.7% 的複合年成長率成長，到 2034 年達到 80,332 億美元。

門診服務是指無需住院即可在門診進行的醫療服務，例如診斷、檢查、治療和手術。這些服務涵蓋多種醫療機構，例如門診手術中心、急診診所和影像中心。隨著全球醫療系統將重心轉向經濟高效、便利且以患者為中心的醫療模式，以減輕醫院負擔，同時改善非緊急醫療需求的就診途徑和治療效果，門診服務市場正在迅速擴張。

醫療成本不斷上漲和縮短住院時間的壓力

醫療成本不斷上漲，迫使醫療保險公司和醫療服務提供者尋求成本更低的替代傳統住院治療的方案，這使得門診服務越來越受歡迎。門診手術中心對相同手術的收費通常比醫院門診部低45%至60%，為保險公司和患者降低成本。美國的聯邦醫療保險（Medicare）等政府計畫透過有利於門診機構的報銷政策積極推廣門診治療。這種成本差異，加上臨床證據表明許多在門診進行的手術可以取得同等甚至更好的效果，正在推動門診市場在所有先進醫療保健系統中持續快速擴張。

贖回限制和監管障礙

保險覆蓋範圍和監管限制方面的區域差異阻礙了門診醫療服務市場潛力的充分發揮。許多私人保險公司仍然嚴格限制門診手術的核准範圍，而政府的報銷率有時甚至不足以涵蓋醫療服務的實際成本。門診手術中心的許可要求因地區而異，給擁有多家機構的業者帶來了合規負擔。此外，一些允許當日出院的醫療程序在某些醫療保險計劃下仍被歸類為“僅限住院”，這限制了它們的臨床應用範圍，並導致不必要的住院，從而增加了整個系統的成本。

微創手術的技術進步

外科技術和醫療設備的創新正將日益複雜的手術從醫院手術室轉移到門診機構。機器人輔助手術、先進的腹腔鏡手術以及改進的麻醉方案，使得以往需要住院數日的手術現在可以安全地進行，並在當天出院。攜帶式診斷設備和遠端醫療的整合進一步拓展了門診診所可提供的服務範圍。這些技術進步創造了巨大的成長機會，因為以往僅限於門診治療的手術計畫現在也已開放，這使得門診診所能夠吸引更多重症患者，並創造新的收入來源。

併發症管理方面的潛在局限性

許多門診機構缺乏過夜後續觀察或重症監護的基礎設施，這引發了人們對如何處理術後意外併發症的擔憂。雖然嚴重不利事件較為罕見，但出血、呼吸抑製或藥物不良反應等情況可能需要緊急轉院，從而危及患者安全。對醫療事故責任的擔憂可能導致一些醫生在門診環境中猶豫是否要進行高風險手術。此外，媒體對門診併發症的負面報導可能會削弱患者的信心，並導致監管機構過度干預，從而可能逆轉多年來在患者從醫院過渡到更合適的護理方面取得的進展。

新冠疫情的影響

新冠疫情對全球門診服務造成了嚴重衝擊，並引發了一場快速變革。疫情初期，為了節省資源、降低感染風險，醫院和門診機構都暫停了擇期手術。然而，隨著疫情發展，由於門診患者數量較少且配備了專用通風系統，其感染控制能力更強，因此吸引了眾多患者和醫護人員。大量手術延期導致大規模門診服務的需求空前高漲。疫情封鎖期間遠距遠端醫療的引入永久擴展了門診模式，如今，線上諮詢已成為許多治療服務的入口。

在預測期內，門診手術中心（ASC）細分市場預計將成為最大的細分市場。

預計在預測期內，門診手術中心 (ASC) 將佔據最大的市場佔有率，這得益於其專業的設施、成本效益和手術量處理能力。這些設施專為日間手術而設計，並配備專用手術室、恢復室和專業人員，以最佳化手術處理能力。每年，ASC 在眼科、胃腸病學、整形外科和疼痛管理等領域進行數百萬例手術，且病患滿意度高於醫院。醫生自主運作的獎勵有助於提高效率和質量，而 ASC 因其降低的營運成本和避免住院而受到保險公司的青睞，從而推動更多患者選擇門診手術。

在預測期內，眼科領域預計將呈現最高的複合年成長率。

在預測期內，眼科領域預計將呈現最高的成長率，這反映了眼科手術與門診模式的高度契合性。白內障手術、屈光矯正手術（如LASIK）以及視網膜疾病的玻璃體內注射治療幾乎無一例外地在門診進行，因為這些手術耗時短、麻醉需求極低且恢復迅速。隨著全球人口老化，需要手術介入的老齡化性白內障和老齡化黃斑部病變病例數正在急劇增加。飛秒雷射白內障手術和高階人工水晶體等技術的不斷進步，不僅增加了手術數量，也吸引了願意承擔更高費用以獲得更好治療效果的患者，從而進一步加速了該領域的擴張。

市佔率最大的地區

在整個預測期內，北美地區預計將保持最大的市場佔有率，這得益於其最成熟的門診服務基礎設施和有利的報銷政策。美國在門診手術中心的普及方面處於主導，數千家獲得聯邦醫療保險（Medicare）認證的機構每年在所有主要專科領域開展數百萬例手術。強大的私人保險市場透過分級網路和經濟獎勵，積極引導患者選擇費用較低的門診機構。聯邦醫療保險和醫療補助服務中心（CMS）的監管簡化措施正在擴大核准的手術項目範圍，同時醫生所有的醫療機構仍然受到法律保護。這些結構性優勢，加上高昂的人均醫療保健成本，鞏固了北美在市場上的主導地位。

複合年成長率最高的地區

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中產階級人口的快速成長、慢性病負擔的日益加重以及醫療衛生體系的現代化。隨著都市化的加速，包括中國、印度和東南亞國家在內的各國對便利且價格合理的外科上的照護需求空前高漲。各國政府為促進醫療衛生基礎建設，制定了擴大門診設施的具體目標，以緩解公立醫院的壓力。醫療旅遊也進一步推動了泰國、馬來西亞和新加坡等國高品質門診手術中心的成長。隨著經濟高效的西方醫療模式在全部區域影響力的不斷擴大，亞太地區正崛起為門診服務成長最快的市場。

免費客製化服務

所有購買此報告的客戶均可享受以下免費自訂選項之一。

  • 企業概況
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 透過產品系列、地理覆蓋範圍和策略聯盟對標領先企業。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 成長機會和重點投資領域
  • 工業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球門診醫療服務市場：依服務類型分類

  • 基層醫療服務
  • 專業醫療服務
  • 診斷服務
  • 外科服務
  • 治療和復健服務
  • 預防保健服務

第6章 全球門診醫療服務市場：依機構類型分類

  • 門診手術中心（ASC）
  • 急診中心
  • 門診部（醫院內）
  • 獨立診所
  • 診斷和影像中心

第7章 全球門診醫療服務市場：依醫療專科分類

  • 整形外科
  • 眼科
  • 胃腸病學
  • 循環系統
  • 疼痛管理
  • 整形及美容手術
  • 一般外科
  • 其他

第8章：全球門診醫療服務市場：以所有權類型分類

  • 醫院所屬中心
  • 醫生診所
  • 連鎖設施
  • 獨立中心

第9章 全球門診醫療服務市場：依服務提供方式分類

  • 面對面諮詢
  • 遠端醫療
  • 混合護理

第10章 全球門診護理服務市場：依最終用戶分類

  • 醫院
  • 醫生團隊
  • 獨立診所
  • 企業醫療保健提供者

第11章 全球門診醫療服務市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 其他
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲地區

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • HCA Healthcare Inc.
  • Tenet Healthcare Corporation
  • Surgery Partners Inc.
  • Envision Healthcare Corporation
  • Community Health Systems Inc.
  • Universal Health Services Inc.
  • AmSurg Corporation
  • SCA Health
  • MEDNAX Inc.
  • UnitedHealth Group Incorporated
  • Fresenius Medical Care AG
  • DaVita Inc.
  • Ramsay Health Care Limited
  • Spire Healthcare Group plc
  • Nuffield Health
Product Code: SMRC36232

According to Stratistics MRC, the Global Ambulatory Services Market is accounted for $4781.6 billion in 2026 and is expected to reach $8033.2 billion by 2034 growing at a CAGR of 6.7% during the forecast period. Ambulatory services refer to medical care provided on an outpatient basis, including diagnosis, consultation, treatment, and surgery without requiring overnight hospital admission. These services encompass a wide range of facilities such as ambulatory surgical centers, urgent care clinics, and diagnostic imaging centers. The market is expanding rapidly as healthcare systems worldwide shift focus toward cost-effective, convenient, and patient-centered care models that reduce hospital burdens while improving accessibility and outcomes for non-emergency medical needs.

Market Dynamics:

Driver:

Rising healthcare costs and pressure to reduce hospital admissions

Escalating medical expenses are forcing healthcare payers and providers to seek lower-cost alternatives to traditional inpatient care, making ambulatory services increasingly attractive. Ambulatory surgical centers typically charge 45-60% less than hospital outpatient departments for identical procedures, generating substantial savings for insurers and patients. Government programs like Medicare in the US actively promote outpatient care through reimbursement policies favoring ambulatory settings. This cost differential, combined with clinical evidence showing comparable or better outcomes for many procedures performed in ambulatory facilities, continues to drive rapid market expansion across all developed healthcare systems.

Restraint:

Reimbursement limitations and regulatory barriers

Variations in insurance coverage and regulatory restrictions across regions constrain the full potential of ambulatory services market growth. Many private insurers still maintain restrictive lists of procedures approved for ambulatory settings, while government reimbursement rates sometimes fail to cover the actual costs of care delivery. Licensing requirements for ambulatory surgical centers vary substantially between jurisdictions, creating compliance burdens for multi-facility operators. Additionally, some medical procedures with same-day discharge potential remain categorized as inpatient-only in certain healthcare systems, limiting clinical scope and forcing medically unnecessary overnight stays that increase system costs.

Opportunity:

Technological advancements in minimally invasive surgery

Innovations in surgical techniques and medical devices are enabling increasingly complex procedures to migrate from hospital operating rooms to ambulatory settings. Robot-assisted surgery, advanced laparoscopy, and improved anesthetic protocols allow procedures once requiring multiple hospital days to be performed safely with same-day discharge. Portable diagnostic equipment and telemedicine integration further expand the range of services deliverable in ambulatory clinics. These technological developments create substantial growth opportunities as previously restricted procedure categories become eligible for outpatient treatment, allowing ambulatory providers to capture higher-acuity cases and generate additional revenue streams.

Threat:

Potential for complication management limitations

The absence of overnight observation and intensive care capabilities in many ambulatory facilities raises concerns about managing unexpected post-procedural complications. While serious adverse events are rare, conditions such as bleeding, respiratory depression, or adverse drug reactions may require urgent hospital transfer, creating patient safety risks. Medical malpractice liability concerns may discourage some physicians from performing higher-risk procedures in ambulatory settings. Additionally, negative media coverage of complications occurring in outpatient facilities could undermine patient confidence and prompt regulatory overreach, potentially reversing years of progress toward appropriate procedure migration from hospital settings.

Covid-19 Impact:

The COVID-19 pandemic caused severe disruption followed by accelerated transformation of ambulatory services globally. During initial outbreak phases, elective procedures were suspended in both hospital and ambulatory settings to preserve resources and reduce infection risk. However, as the pandemic progressed, ambulatory facilities demonstrated superior infection control capabilities due to lower patient volumes and dedicated ventilation systems, attracting both patients and providers. The backlog of delayed surgeries created unprecedented demand for high-volume outpatient capacity. Telehealth adoption during lockdowns permanently expanded the ambulatory care model, with virtual consultations now serving as entry points for many procedural services.

The Ambulatory Surgical Centers (ASCs) segment is expected to be the largest during the forecast period

The Ambulatory Surgical Centers (ASCs) segment is expected to account for the largest market share during the forecast period, driven by their specialized infrastructure, cost efficiency, and procedure volume capabilities. These facilities are specifically designed for same-day surgical procedures, offering dedicated operating rooms, recovery areas, and specialized staffing that optimize throughput. ASCs perform millions of surgeries annually across ophthalmology, gastroenterology, orthopedics, and pain management, with higher patient satisfaction scores compared to hospital settings. Physician ownership models align incentives toward efficiency and quality, while lower overhead costs and avoidance of overnight stays make ASCs the preferred site for payers driving patient volumes toward ambulatory settings.

The Ophthalmology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Ophthalmology segment is predicted to witness the highest growth rate, reflecting the ideal match between ophthalmic procedures and ambulatory delivery models. Cataract surgery, refractive procedures like LASIK, and intravitreal injections for retinal conditions are performed almost exclusively in ambulatory settings due to their brief duration, minimal anesthesia requirements, and rapid recovery profiles. Aging populations worldwide are driving exponential growth in age-related cataract and macular degeneration cases requiring surgical intervention. Continuous technological advances including femtosecond laser-assisted cataract surgery and premium intraocular lenses increase procedure volumes while attracting patients willing to pay out-of-pocket for enhanced outcomes, further accelerating segment expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by the most mature ambulatory services infrastructure and favorable reimbursement policies. The United States leads in ambulatory surgical center proliferation, with thousands of Medicare-certified facilities performing millions of procedures annually across all major specialties. Strong private insurance markets actively direct patients toward lower-cost ambulatory settings through tiered networks and financial incentives. Regulatory streamlining through the Centers for Medicare & Medicaid Services has expanded approved procedure lists, while physician ownership remains legally protected. These structural advantages, combined with high healthcare spending per capita, secure North America's dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapidly expanding middle-class populations, increasing chronic disease burdens, and healthcare system modernization. Countries including China, India, and Southeast Asian nations are witnessing unprecedented demand for accessible, affordable surgical care as urbanization accelerates. Government initiatives promoting healthcare infrastructure development include specific targets for ambulatory facility expansion to reduce pressure on overburdened public hospitals. Medical tourism further stimulates growth of high-quality ambulatory surgical centers in Thailand, Malaysia, and Singapore. As Western healthcare models demonstrating cost efficiency gain influence across the region, Asia Pacific emerges as the fastest-growing market for ambulatory services.

Key players in the market

Some of the key players in Ambulatory Services Market include HCA Healthcare Inc., Tenet Healthcare Corporation, Surgery Partners Inc., Envision Healthcare Corporation, Community Health Systems Inc., Universal Health Services Inc., AmSurg Corporation, SCA Health, MEDNAX Inc., UnitedHealth Group Incorporated, Fresenius Medical Care AG, DaVita Inc., Ramsay Health Care Limited, Spire Healthcare Group plc, and Nuffield Health.

Key Developments:

In January 2026, Surgery Partners announced a milestone reaching over 180 managed surgical facilities, noting that its musculoskeletal (MSK) and cardiology volumes increased by double digits in 2025.

In December 2025, Envision announced multi-year in-network agreements with Arizona Blue, ensuring stable patient access to its physician services and ambulatory sites in the Southwest.

In October 2025, Tenet completed the sale of its majority interest in Brookwood Baptist Health in Birmingham, AL, to Orlando Health for approximately $910 million, further pivoting the company's portfolio away from traditional inpatient acute care toward ambulatory services.

Service Types Covered:

  • Primary Care Services
  • Specialty Care Services
  • Diagnostic Services
  • Surgical Services
  • Therapeutic & Rehabilitation Services
  • Preventive & Wellness Services

Facility Types Covered:

  • Ambulatory Surgical Centers (ASCs)
  • Urgent Care Centers
  • Outpatient Departments (Hospital-based)
  • Standalone Clinics
  • Diagnostic & Imaging Centers

Clinical Specialties Covered:

  • Orthopedics
  • Ophthalmology
  • Gastroenterology
  • Cardiology
  • Pain Management
  • Plastic & Cosmetic Surgery
  • General Surgery
  • Other Clinical Specialties

Ownership Models Covered:

  • Hospital-owned Centers
  • Physician-owned Centers
  • Chain-based Centers
  • Independent Centers

Delivery Modes Covered:

  • In-person Care
  • Telehealth
  • Hybrid Care

End Users Covered:

  • Hospitals
  • Physician Groups
  • Independent Clinics
  • Corporate Healthcare Providers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Ambulatory Services Market, By Service Type

  • 5.1 Primary Care Services
  • 5.2 Specialty Care Services
  • 5.3 Diagnostic Services
  • 5.4 Surgical Services
  • 5.5 Therapeutic & Rehabilitation Services
  • 5.6 Preventive & Wellness Services

6 Global Ambulatory Services Market, By Facility Type

  • 6.1 Ambulatory Surgical Centers (ASCs)
  • 6.2 Urgent Care Centers
  • 6.3 Outpatient Departments (Hospital-based)
  • 6.4 Standalone Clinics
  • 6.5 Diagnostic & Imaging Centers

7 Global Ambulatory Services Market, By Clinical Specialty

  • 7.1 Orthopedics
  • 7.2 Ophthalmology
  • 7.3 Gastroenterology
  • 7.4 Cardiology
  • 7.5 Pain Management
  • 7.6 Plastic & Cosmetic Surgery
  • 7.7 General Surgery
  • 7.8 Other Clinical Specialties

8 Global Ambulatory Services Market, By Ownership Model

  • 8.1 Hospital-owned Centers
  • 8.2 Physician-owned Centers
  • 8.3 Chain-based Centers
  • 8.4 Independent Centers

9 Global Ambulatory Services Market, By Delivery Mode

  • 9.1 In-person Care
  • 9.2 Telehealth
  • 9.3 Hybrid Care

10 Global Ambulatory Services Market, By End User

  • 10.1 Hospitals
  • 10.2 Physician Groups
  • 10.3 Independent Clinics
  • 10.4 Corporate Healthcare Providers

11 Global Ambulatory Services Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 HCA Healthcare Inc.
  • 14.2 Tenet Healthcare Corporation
  • 14.3 Surgery Partners Inc.
  • 14.4 Envision Healthcare Corporation
  • 14.5 Community Health Systems Inc.
  • 14.6 Universal Health Services Inc.
  • 14.7 AmSurg Corporation
  • 14.8 SCA Health
  • 14.9 MEDNAX Inc.
  • 14.10 UnitedHealth Group Incorporated
  • 14.11 Fresenius Medical Care AG
  • 14.12 DaVita Inc.
  • 14.13 Ramsay Health Care Limited
  • 14.14 Spire Healthcare Group plc
  • 14.15 Nuffield Health

List of Tables

  • Table 1 Global Ambulatory Services Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Ambulatory Services Market Outlook, By Service Type (2023-2034) ($MN)
  • Table 3 Global Ambulatory Services Market Outlook, By Primary Care Services (2023-2034) ($MN)
  • Table 4 Global Ambulatory Services Market Outlook, By Specialty Care Services (2023-2034) ($MN)
  • Table 5 Global Ambulatory Services Market Outlook, By Diagnostic Services (2023-2034) ($MN)
  • Table 6 Global Ambulatory Services Market Outlook, By Surgical Services (2023-2034) ($MN)
  • Table 7 Global Ambulatory Services Market Outlook, By Therapeutic & Rehabilitation Services (2023-2034) ($MN)
  • Table 8 Global Ambulatory Services Market Outlook, By Preventive & Wellness Services (2023-2034) ($MN)
  • Table 9 Global Ambulatory Services Market Outlook, By Facility Type (2023-2034) ($MN)
  • Table 10 Global Ambulatory Services Market Outlook, By Ambulatory Surgical Centers (ASCs) (2023-2034) ($MN)
  • Table 11 Global Ambulatory Services Market Outlook, By Urgent Care Centers (2023-2034) ($MN)
  • Table 12 Global Ambulatory Services Market Outlook, By Outpatient Departments (Hospital-based) (2023-2034) ($MN)
  • Table 13 Global Ambulatory Services Market Outlook, By Standalone Clinics (2023-2034) ($MN)
  • Table 14 Global Ambulatory Services Market Outlook, By Diagnostic & Imaging Centers (2023-2034) ($MN)
  • Table 15 Global Ambulatory Services Market Outlook, By Clinical Specialty (2023-2034) ($MN)
  • Table 16 Global Ambulatory Services Market Outlook, By Orthopedics (2023-2034) ($MN)
  • Table 17 Global Ambulatory Services Market Outlook, By Ophthalmology (2023-2034) ($MN)
  • Table 18 Global Ambulatory Services Market Outlook, By Gastroenterology (2023-2034) ($MN)
  • Table 19 Global Ambulatory Services Market Outlook, By Cardiology (2023-2034) ($MN)
  • Table 20 Global Ambulatory Services Market Outlook, By Pain Management (2023-2034) ($MN)
  • Table 21 Global Ambulatory Services Market Outlook, By Plastic & Cosmetic Surgery (2023-2034) ($MN)
  • Table 22 Global Ambulatory Services Market Outlook, By General Surgery (2023-2034) ($MN)
  • Table 23 Global Ambulatory Services Market Outlook, By Other Clinical Specialties (2023-2034) ($MN)
  • Table 24 Global Ambulatory Services Market Outlook, By Ownership Model (2023-2034) ($MN)
  • Table 25 Global Ambulatory Services Market Outlook, By Hospital-owned Centers (2023-2034) ($MN)
  • Table 26 Global Ambulatory Services Market Outlook, By Physician-owned Centers (2023-2034) ($MN)
  • Table 27 Global Ambulatory Services Market Outlook, By Chain-based Centers (2023-2034) ($MN)
  • Table 28 Global Ambulatory Services Market Outlook, By Independent Centers (2023-2034) ($MN)
  • Table 29 Global Ambulatory Services Market Outlook, By Delivery Mode (2023-2034) ($MN)
  • Table 30 Global Ambulatory Services Market Outlook, By In-person Care (2023-2034) ($MN)
  • Table 31 Global Ambulatory Services Market Outlook, By Telehealth (2023-2034) ($MN)
  • Table 32 Global Ambulatory Services Market Outlook, By Hybrid Care (2023-2034) ($MN)
  • Table 33 Global Ambulatory Services Market Outlook, By End User (2023-2034) ($MN)
  • Table 34 Global Ambulatory Services Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 35 Global Ambulatory Services Market Outlook, By Physician Groups (2023-2034) ($MN)
  • Table 36 Global Ambulatory Services Market Outlook, By Independent Clinics (2023-2034) ($MN)
  • Table 37 Global Ambulatory Services Market Outlook, By Corporate Healthcare Providers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.